Post by brotherm1 on Aug 8, 2016 22:54:20 GMT -5
From Mike Castagna at today's conference call, "
"The next program which I’ll share with you which is our earliest indicator of our weekly prescriptions is our Afrezza CoPay card program. This is administered by McKesson and we moved it and launched it the last week of July to now $15 copay per month and we’re hoping [indiscernible] on a couple other basals at about $15 per month and we’re hopeful that doctors will take a patient, simplify their life to a basal one shot a day along with Afrezza for $30 a month on the commercial side of the patients – commercially insured patients. And we really try to streamline this to make it easy $15 a month consistently, so there’s not a lot of confusion between the different types of programs out there.
The other thing you’ll hear us launch which is just a short term pilot is a voucher program. This voucher program will be good for one month sample of the titration pack and this is meant to drive demand pull through to the wholesale channel to ensure the local pharmacies are stocking it as well as a supplement for our current sample program."
Regarding the one shot per day basals mentioned, I assume he is referring to Tresiba and another one or so? I believe some on this board somewhere recently speculated and discussed the possibility of somehow pairing Afrezza with a basal such as Tresiba but it did not sound very feasible as the basal companies might not at all be interested in seeing Afrezza possibly competing with their own meal time insulins should they have any? Just trying to imagine how this proposed and integrated one copay for both a basal and Afrezza together could be set up and implemented among doctors to seemingly pair the two for a combined prescription?
"The next program which I’ll share with you which is our earliest indicator of our weekly prescriptions is our Afrezza CoPay card program. This is administered by McKesson and we moved it and launched it the last week of July to now $15 copay per month and we’re hoping [indiscernible] on a couple other basals at about $15 per month and we’re hopeful that doctors will take a patient, simplify their life to a basal one shot a day along with Afrezza for $30 a month on the commercial side of the patients – commercially insured patients. And we really try to streamline this to make it easy $15 a month consistently, so there’s not a lot of confusion between the different types of programs out there.
The other thing you’ll hear us launch which is just a short term pilot is a voucher program. This voucher program will be good for one month sample of the titration pack and this is meant to drive demand pull through to the wholesale channel to ensure the local pharmacies are stocking it as well as a supplement for our current sample program."
Regarding the one shot per day basals mentioned, I assume he is referring to Tresiba and another one or so? I believe some on this board somewhere recently speculated and discussed the possibility of somehow pairing Afrezza with a basal such as Tresiba but it did not sound very feasible as the basal companies might not at all be interested in seeing Afrezza possibly competing with their own meal time insulins should they have any? Just trying to imagine how this proposed and integrated one copay for both a basal and Afrezza together could be set up and implemented among doctors to seemingly pair the two for a combined prescription?